Published in Gene Therapy Weekly, December 22nd, 2005
Lentiviral vectors are highly adapted delivery vehicles that can transport therapeutic genes into cells with high efficiency and stability. Utilizing its proprietary LentiMax vector, an HIV-1 based lentiviral vector system synthetically optimized for high titer and safety, Lentigen will manufacture custom lentiviral vectors. Alternatively, Lentigen can manufacture any...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.